Reasons for Lack of Improvement in Treatment With Evidence-Based Therapies in Heart Failure
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Titration of Medical Therapy for Heart Failure With Reduced Ejection FractionJACC, 2019
- Validity of Performance and Outcome Measures for Heart FailureCirculation: Heart Failure, 2018
- Medical Therapy for Heart Failure With Reduced Ejection FractionJACC, 2018
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart FailureJACC, 2017
- Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart AssociationCirculation, 2016
- Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology PracticesCirculation, 2010
- Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart FailureEuropean Heart Journal, 2005
- The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe Part 2: treatmentEuropean Heart Journal, 2003